Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF) Financials
Stock symbol SFOSF is outdated, potentially delisted? Maybe it is available on other exchange?
SFOSF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2025 | 16.2 billion | 7.9 billion |
| Dec. 31, 2024 | 16.1 billion | 7.9 billion |
| Sept. 30, 2024 | 16.4 billion | 8.0 billion |
| June 30, 2024 | 15.9 billion | 7.7 billion |
SFOSF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2025 | -8.7 million | ? |
| Dec. 31, 2024 | 14.7 million | ? |
| Sept. 30, 2024 | 20.8 million | ? |
| June 30, 2024 | 34.1 million | ? |
SFOSF Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| March 31, 2025 | ? |
| Dec. 31, 2024 | ? |
| Sept. 30, 2024 | 112.0 million |
| June 30, 2024 | 84.6 million |
SFOSF Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2025 | 2.2 billion | 2.0 billion | 362.0 million |
| Dec. 31, 2024 | 2.2 billion | 1.8 billion | 348.2 million |
| Sept. 30, 2024 | 2.2 billion | 1.6 billion | 315.9 million |
| June 30, 2024 | 2.2 billion | 1.6 billion | 269.4 million |
SFOSF Shares Outstanding
SFOSF Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2025 | 154.0 million | 101.5 million | 426.7 million | 292.7 million |
| Dec. 31, 2024 | 189.5 million | 136.5 million | -447.1 million | 286.0 million |
| Sept. 30, 2024 | 133.0 million | 112.0 million | 939.8 million | 565.1 million |
| June 30, 2024 | 115.4 million | 128.9 million | 392.9 million | 278.8 million |
SFOSF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2025 | 1.3 billion | 677.4 million |
| Dec. 31, 2024 | 1.4 billion | 750.2 million |
| Sept. 30, 2024 | 1.5 billion | 773.1 million |
| June 30, 2024 | 1.4 billion | 789.3 million |
SFOSF
Price: $2.30
52 week price:
Dividend Yield: 1.67%
5-year range yield:
Forward Dividend Yield: 1.94%
Payout Ratio Range:
Dividend Per Share: 0.04 USD
Earnings Per Share: 0.15 USD
P/E Ratio: 17.80
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 10.5 billion
Average Dividend Frequency: 1
Years Paying Dividends: 8